EU member states concerned over drug information provisions in pharma package
This article was originally published in SRA
Executive Summary
European Union member state ministers have welcomed the pharmacovigilance and anticounterfeiting proposals in the “pharmaceutical package” of draft legislation from the European Commission. However, they again expressed concerns about the proposal in the package to allow pharmaceutical companies to provide drug information directly to patients.